What does DOKTERS DARCIS-VANBILSEN do?

DOKTERS DARCIS-VANBILSEN is a specialist medical practice in Lummen. Private Limited, started on 20 October 2006, 2 establishments.

What is the address of DOKTERS DARCIS-VANBILSEN?

The registered office of DOKTERS DARCIS-VANBILSEN is located at Priesterse Heidestraat 98, 3560 Lummen.

Is DOKTERS DARCIS-VANBILSEN still active?

Yes. According to the CBE (30 October 2026) DOKTERS DARCIS-VANBILSEN is active, legal situation “Normale toestand”, started on 20 October 2006.

Is DOKTERS DARCIS-VANBILSEN registered on Peppol?

Yes, DOKTERS DARCIS-VANBILSEN is registered on the Peppol network with ID 0208:0884433726.

What is the enterprise number of DOKTERS DARCIS-VANBILSEN?

The enterprise number of DOKTERS DARCIS-VANBILSEN is BE0884433726.

When was DOKTERS DARCIS-VANBILSEN founded?

DOKTERS DARCIS-VANBILSEN was founded on 20 October 2006.

Who are the directors of DOKTERS DARCIS-VANBILSEN?

According to the 2025 annual accounts, the directors of DOKTERS DARCIS-VANBILSEN are: Kathleen Vanbilsen, Johan Darcis.

Is DOKTERS DARCIS-VANBILSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 October 2006; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DOKTERS DARCIS-VANBILSEN make in 2025?

DOKTERS DARCIS-VANBILSEN posted a profit after taxes of € 216,444 in financial year 2025.

What is the revenue of DOKTERS DARCIS-VANBILSEN?

As a small company, DOKTERS DARCIS-VANBILSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 357,783.

DOKTERS DARCIS-VANBILSEN (Private Limited) - Lummen

Dossier DOKTERS DARCIS-VANBILSEN, printed on 30 October 2026 from databakkes.be/en/0884433726/dokters-darcis-vanbilsen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTERS DARCIS-VANBILSEN from Lummen, company number BE0884433726, closed financial year 2025 with a result of € 216,444 after tax. For that financial year DOKTERS DARCIS-VANBILSEN recorded a gross margin of € 357,783 and equity of € 999,547. Compared with financial year 2024, the result moved from € 190,487 to € 216,444. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Healthy

€ 999,547

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 216,444

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 563,408

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 329,691 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 239

▼ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,312

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 9,873

▼ 47% vs 2024

€ 9,096 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 3,310

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 60,692

▲ 20% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 244,488 Gross margin 2022: € 244,488 First fiscal year in the series	€ 276,892 Gross margin 2023: € 276,892 ▲ 13% vs 2022 (€ 244,488) Favourable step	€ 314,108 Gross margin 2024: € 314,108 ▲ 13% vs 2023 (€ 276,892) Favourable step	€ 357,783 Gross margin 2025: € 357,783 ▲ 14% vs 2024 (€ 314,108) Favourable step	▲ 14%
Profit after taxes	€ 129,398 Profit after taxes 2022: € 129,398 First fiscal year in the series	€ 162,487 Profit after taxes 2023: € 162,487 ▲ 26% vs 2022 (€ 129,398) Favourable step	€ 190,487 Profit after taxes 2024: € 190,487 ▲ 17% vs 2023 (€ 162,487) Favourable step	€ 216,444 Profit after taxes 2025: € 216,444 ▲ 14% vs 2024 (€ 190,487) Favourable step	▲ 14%
Equity	€ 881,125 Equity 2022: € 881,125 First fiscal year in the series	€ 922,307 Equity 2023: € 922,307 ▲ 5% vs 2022 (€ 881,125) Favourable step	€ 1,112,794 Equity 2024: € 1,112,794 ▲ 21% vs 2023 (€ 922,307) Favourable step	€ 999,547 Equity 2025: € 999,547 ▼ 10% vs 2024 (€ 1,112,794) Unfavourable step	▼ 10%
Total debts	€ 178,666 Total debts 2022: € 178,666 First fiscal year in the series	€ 245,717 Total debts 2023: € 245,717 ▲ 38% vs 2022 (€ 178,666) Unfavourable step	€ 232,191 Total debts 2024: € 232,191 ▼ 6% vs 2023 (€ 245,717) Favourable step	€ 210,184 Total debts 2025: € 210,184 ▼ 9% vs 2024 (€ 232,191) Favourable step	▼ 9%
Cash	€ 371,404 Cash 2022: € 371,404 First fiscal year in the series	€ 365,198 Cash 2023: € 365,198 ▼ 2% vs 2022 (€ 371,404) Unfavourable step	€ 680,933 Cash 2024: € 680,933 ▲ 86% vs 2023 (€ 365,198) Favourable step	€ 563,408 Cash 2025: € 563,408 ▼ 17% vs 2024 (€ 680,933) Unfavourable step	▼ 17%
Land & buildings	€ 545,361 Land & buildings 2022: € 545,361 First fiscal year in the series	€ 518,587 Land & buildings 2023: € 518,587 ▼ 5% vs 2022 (€ 545,361) Unchanged	€ 501,761 Land & buildings 2024: € 501,761 ▼ 3% vs 2023 (€ 518,587) Unchanged	€ 469,397 Land & buildings 2025: € 469,397 ▼ 6% vs 2024 (€ 501,761) Unchanged	▼ 6%
Retained profit	€ 874,925 Retained profit 2022: € 874,925 First fiscal year in the series	€ 903,707 Retained profit 2023: € 903,707 ▲ 3% vs 2022 (€ 874,925) Favourable step	€ 1,094,194 Retained profit 2024: € 1,094,194 ▲ 21% vs 2023 (€ 903,707) Favourable step	€ 980,947 Retained profit 2025: € 980,947 ▼ 10% vs 2024 (€ 1,094,194) Unfavourable step	▼ 10%
Dividend	€ 168,712 Dividend 2022: € 168,712 First fiscal year in the series	€ 133,705 Dividend 2023: € 133,705 ▼ 21% vs 2022 (€ 168,712) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 133,705) Unchanged	€ 329,691 Dividend 2025: € 329,691 Unchanged (€ 0) Unchanged
Bank debt	€ 34,922 Bank debt 2022: € 34,922 First fiscal year in the series	€ 26,930 Bank debt 2023: € 26,930 ▼ 23% vs 2022 (€ 34,922) Favourable step	€ 18,585 Bank debt 2024: € 18,585 ▼ 31% vs 2023 (€ 26,930) Favourable step	€ 9,873 Bank debt 2025: € 9,873 ▼ 47% vs 2024 (€ 18,585) Favourable step	▼ 47%
Balance sheet total	€ 1,059,791 Balance sheet total 2022: € 1,059,791 First fiscal year in the series	€ 1,168,024 Balance sheet total 2023: € 1,168,024 ▲ 10% vs 2022 (€ 1,059,791) Unchanged	€ 1,344,985 Balance sheet total 2024: € 1,344,985 ▲ 15% vs 2023 (€ 1,168,024) Unchanged	€ 1,209,731 Balance sheet total 2025: € 1,209,731 ▼ 10% vs 2024 (€ 1,344,985) Unchanged	▼ 10%

Key figures of DOKTERS DARCIS-VANBILSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTERS DARCIS-VANBILSEN?

What happened at DOKTERS DARCIS-VANBILSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 216,444 (▲ 14% vs 2024). filed late Source: NBB ↗
Jan 1, 2017 New establishment in Heusden-Zolder. KBO
Oct 20, 2006 New establishment in Lummen. KBO
Oct 20, 2006 Start of the company according to the CBE. KBO
2006 Kathleen Vanbilsen became a director. NBB
2006 Johan Darcis became a director. NBB

In short

From € 129,398 profit in 2022 to € 216,444 profit in 2025.

Paid € 313,714 in corporate taxes since 2022.

Best year ever: 2025, with € 216,444 profit.

Paid out € 632,108 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Kathleen Vanbilsen Johan Darcis

DOKTERS DARCIS-VANBILSEN

NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE

Behind DOKTERS DARCIS-VANBILSEN are Kathleen Vanbilsen and Johan Darcis. Johan Darcis is also behind NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE.

Directors

According to the 2025 annual accounts

Kathleen Vanbilsen

Director

since 2006

Johan Darcis

Director

Also active at: NEUROLOGIE-FYSISCHE GENEESKUNDE EN REVALIDATIE

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Priesterse Heidestraat 98

3560 Lummen

2.303.834.726

Pastoor Paquaylaan 129

3550 Heusden-Zolder

Active since 1 January 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0884.433.726
VAT number: BE 0884.433.726
Registered office: Priesterse Heidestraat 98, 3560 Lummen
Names & denominations: DOKTERS DARCIS-VANBILSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 October 2006
Peppol: Active · Active since 26 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗